• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鱼类肠道中无乳链球菌减毒疫苗菌株 YM001 的时空分布及其对黏膜相关免疫细胞的影响。

Spatiotemporal distribution of Streptococcus agalactiae attenuated vaccine strain YM001 in the intestinal tract of tilapia and its effect on mucosal associated immune cells.

机构信息

Guangxi Key Laboratory for Aquatic Genetic Breeding and Healthy Aquaculture, Guangxi Institute of Fisheries, Nanning, 530021, China.

Guangxi Key Laboratory for Aquatic Genetic Breeding and Healthy Aquaculture, Guangxi Institute of Fisheries, Nanning, 530021, China.

出版信息

Fish Shellfish Immunol. 2019 Apr;87:714-720. doi: 10.1016/j.fsi.2019.02.003. Epub 2019 Feb 7.

DOI:10.1016/j.fsi.2019.02.003
PMID:30738148
Abstract

In this study, the tilapia was orally vaccinated by the attenuated Streptococcus agalactiae(S. agalactiae) strain YM001, and the distribution and the pathological effect of strain YM001 in different intestinal segments of tilapia were evaluated by real-time PCR(qPCR), immunohistochemistry(IHC) and histomorphology. The qPCR results showed that the number of bacteria was the highest in the intestinal tracts at 12 h post oral gavage in the YM001 group, then began to decrease sharply and eliminated at 7 d. And the number of bacteria was highest in the foregut, hindgut, and rectum at 12 h, 24 h, and 3 d, respectively. IHC indicated that bacteria mainly distributed in the margin epithelium and the goblet cells at 12 h - 24 h, and in the submucosa and muscle layer in the YM001 group in 3 d post gavage, then almost disappeared at 7 d. Histological examination of intestines post gavage displayed that an inflammation was observed at 7 d in the YM001 group and the intestinal structure was fully recovered at 15 d. and the intestinal structure was fully recovered at 15 d. Conclusion: The attenuated S. agalactiae vaccine strain YM001 could enter the intestinal tissue after oral gavage and had a strong spatial and temporal selectivity in the intestinal tract, which could cause obvious mucosal immune response and mild pathological reaction, but the pathological change could be gradually repaired with the extinction of bacteria in the body.

摘要

在这项研究中,牙鲆经口接种减毒马链球菌(Streptococcus agalactiae)YM001 菌株,通过实时 PCR(qPCR)、免疫组织化学(IHC)和组织形态学评估了 YM001 菌株在牙鲆不同肠道段的分布和病理效应。qPCR 结果显示,YM001 组在口服灌胃后 12 h 肠道细菌数量最高,然后开始急剧下降,并在 7 d 时被清除。细菌数量在 12 h、24 h 和 3 d 时分别在前肠、后肠和直肠中最高。IHC 表明,细菌主要分布在 12 h-24 h 的边缘上皮和杯状细胞中,在灌胃后 3 d 的 YM001 组中分布在黏膜下层和肌肉层,然后在 7 d 时几乎消失。肠道灌胃后的组织学检查显示,YM001 组在 7 d 时出现炎症,15 d 时肠道结构完全恢复。结论:减毒马链球菌疫苗株 YM001 经口服灌胃后可进入肠道组织,在肠道内具有很强的时空选择性,可引起明显的黏膜免疫反应和轻微的病理反应,但随着体内细菌的消失,病理变化可逐渐得到修复。

相似文献

1
Spatiotemporal distribution of Streptococcus agalactiae attenuated vaccine strain YM001 in the intestinal tract of tilapia and its effect on mucosal associated immune cells.鱼类肠道中无乳链球菌减毒疫苗菌株 YM001 的时空分布及其对黏膜相关免疫细胞的影响。
Fish Shellfish Immunol. 2019 Apr;87:714-720. doi: 10.1016/j.fsi.2019.02.003. Epub 2019 Feb 7.
2
Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro.通过体外连续传代开发用于罗非鱼的减毒活无乳链球菌疫苗。
Fish Shellfish Immunol. 2015 Aug;45(2):955-63. doi: 10.1016/j.fsi.2015.06.014. Epub 2015 Jun 15.
3
Development of an attenuated oral vaccine strain of tilapia Group B Streptococci serotype Ia by gene knockout technology.利用基因敲除技术开发减弱毒力的鳜鱼 B 群链球菌 Ia 血清型口服疫苗株。
Fish Shellfish Immunol. 2019 Oct;93:924-933. doi: 10.1016/j.fsi.2019.07.081. Epub 2019 Jul 30.
4
Large-scale profiling of the proteome and dual transcriptome in Nile tilapia (Oreochromis niloticus) challenged with low- and high-virulence strains of Streptococcus agalactiae.大规模分析尼罗罗非鱼(Oreochromis niloticus)在受到低毒力和高毒力链球菌菌株挑战时的蛋白质组和双转录组。
Fish Shellfish Immunol. 2020 May;100:386-396. doi: 10.1016/j.fsi.2020.03.008. Epub 2020 Mar 9.
5
Effects of Attenuated Strain YM001 on Intestinal Microbiota of Tilapia Are Recoverable.减毒菌株YM001对罗非鱼肠道微生物群的影响是可恢复的。
Front Microbiol. 2019 Jan 9;9:3251. doi: 10.3389/fmicb.2018.03251. eCollection 2018.
6
Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture.用于罗非鱼(尼罗罗非鱼)养殖的减毒耐红霉素无乳链球菌疫苗的研制。
J Fish Dis. 2019 May;42(5):693-701. doi: 10.1111/jfd.12977. Epub 2019 Mar 20.
7
An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).一种针对养殖尼罗罗非鱼(Oreochromis niloticus)无乳链球菌感染的有效减毒活疫苗。
Fish Shellfish Immunol. 2020 Mar;98:853-859. doi: 10.1016/j.fsi.2019.11.044. Epub 2019 Nov 18.
8
Comparative genome analysis identifies two large deletions in the genome of highly-passaged attenuated Streptococcus agalactiae strain YM001 compared to the parental pathogenic strain HN016.比较基因组分析表明,与亲本致病菌株HN016相比,高传代减毒无乳链球菌菌株YM001的基因组中存在两个大片段缺失。
BMC Genomics. 2015 Nov 4;16:897. doi: 10.1186/s12864-015-2026-y.
9
Efficacy of live attenuated vaccine derived from the Streptococcus agalactiae on the immune responses of Oreochromis niloticus.从无乳链球菌制备的活疫苗对奥利亚罗非鱼免疫反应的效力。
Fish Shellfish Immunol. 2019 Jul;90:235-243. doi: 10.1016/j.fsi.2019.04.052. Epub 2019 Apr 19.
10
Recombinant lactococcal-based oral vaccine for protection against Streptococcus agalactiae infections in tilapia (Oreochromis niloticus).基于重组乳球菌的口服疫苗预防罗非鱼(Oreochromis niloticus)无乳链球菌感染。
Fish Shellfish Immunol. 2024 Jun;149:109572. doi: 10.1016/j.fsi.2024.109572. Epub 2024 Apr 16.

引用本文的文献

1
ATCC 393 Cannot Colonize the Gastrointestinal Tract of Crucian Carp.美国典型培养物保藏中心393株不能在鲫鱼胃肠道定殖。
Microorganisms. 2021 Dec 9;9(12):2547. doi: 10.3390/microorganisms9122547.
2
Efficacy of Feed-Based Formalin-Killed Vaccine of Stimulates the Gut-Associated Lymphoid Tissues and Immune Response of Red Hybrid Tilapia.基于饲料的福尔马林灭活疫苗对红罗非鱼肠道相关淋巴组织和免疫反应的刺激效果。
Vaccines (Basel). 2021 Jan 14;9(1):51. doi: 10.3390/vaccines9010051.